{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T17:01:35Z","timestamp":1790442095106,"version":"4.1.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T00:00:00Z","timestamp":1612742400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T00:00:00Z","timestamp":1612742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Synaptic failure is one of the principal events associated with cognitive dysfunction in Alzheimer\u2019s disease (AD). Preservation of existing synapses and prevention of synaptic loss are promising strategies to preserve cognitive function in AD patients. As a potent natural anti-oxidant, anti-amyloid, and anti-inflammatory polyphenol, curcumin (Cur) shows great promise as a therapy for AD. However, hydrophobicity of natural Cur limits its solubility, stability, bioavailability, and clinical utility for AD therapy. We have demonstrated that solid lipid curcumin particles (SLCP) have greater therapeutic potential than natural Cur in vitro and in vivo models of AD. In the present study, we have investigated whether SLCP has any preservative role on affected dendritic spines and synaptic markers in 5xFAD mice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Six- and 12-month-old 5xFAD and age-matched wild-type mice received oral administration of SLCP (100\u2009mg\/kg body weight) or equivalent amounts of vehicle for 2\u2009months. Neuronal morphology, neurodegeneration, and amyloid plaque load were investigated from prefrontal cortex (PFC), entorhinal cortex (EC), CA1, CA3, and the subicular complex (SC). In addition, the dendritic spine density from apical and basal branches was studied by Golgi-Cox stain. Further, synaptic markers, such as synaptophysin, PSD95, Shank, Homer, Drebrin, Kalirin-7, CREB, and phosphorylated CREB (pCREB) were studied using Western blots. Finally, cognitive and motor functions were assessed using open-field, novel object recognition (NOR) and Morris water maze (MWM) tasks after treatment with SLCP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We observed an increased number of pyknotic and degenerated cells\u00a0in all these brain areas in 5xFAD mice and SLCP treatment partially protected against those losses. Decrease in dendritic arborization and dendritic spine density from primary, secondary, and tertiary apical and basal branches were observed in PFC, EC, CA1, and CA3 in both 6- and 12-month-old 5xFAD mice, and SLCP treatments partially preserved the normal morphology of these dendritic spines. In addition, pre- and postsynaptic protein markers were also restored by SLCP treatment. Furthermore, SLCP treatment improved NOR and cognitive function in 5xFAD mice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Overall, these findings indicate that use of SLCP exerts neuroprotective properties by decreasing amyloid plaque burden, preventing neuronal death, and preserving dendritic spine density and synaptic markers in the 5xFAD mice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13195-021-00769-9","type":"journal-article","created":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T18:00:13Z","timestamp":1612807213000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["RETRACTED ARTICLE: Preservation of dendritic spine morphology and postsynaptic signaling markers after treatment with solid lipid curcumin particles in the 5xFAD mouse model of Alzheimer\u2019s amyloidosis"],"prefix":"10.1186","volume":"13","author":[{"given":"Panchanan","family":"Maiti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zackary","family":"Bowers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Bourcier-Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarod","family":"Morse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary L.","family":"Dunbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,8]]},"reference":[{"issue":"1","key":"769_CR1","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1056\/NEJMra040223","volume":"351","author":"JL Cummings","year":"2004","unstructured":"Cummings JL. Alzheimer\u2019s disease. N Engl J Med. 2004;351(1):56\u201367.","journal-title":"N Engl J Med"},{"key":"769_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2014.117","volume":"47","author":"A Ciechanover","year":"2015","unstructured":"Ciechanover A, Kwon YT. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies. Exp Mol Med. 2015;47:e147.","journal-title":"Exp Mol Med"},{"issue":"11","key":"769_CR3","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/ncb1104-1054","volume":"6","author":"DJ Selkoe","year":"2004","unstructured":"Selkoe DJ. Biology of protein misfolding: the examples of Alzheimer\u2019s and Parkinson\u2019s diseases. Nat Biol. 2004;6(11):1054\u201361.","journal-title":"Nat Biol"},{"issue":"1","key":"769_CR4","doi-asserted-by":"publisher","first-page":"88","DOI":"10.4161\/cam.3.1.7402","volume":"3","author":"A Gella","year":"2009","unstructured":"Gella A, Durany N. Oxidative stress in Alzheimer disease. Adh Migr. 2009;3(1):88\u201393.","journal-title":"Adh Migr"},{"issue":"10","key":"769_CR5","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","volume":"12","author":"J Hardy","year":"1991","unstructured":"Hardy J, Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimer\u2019s disease. Trends Pharmacol Sci. 1991;12(10):383\u20138.","journal-title":"Trends Pharmacol Sci"},{"issue":"11","key":"769_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015477","volume":"5","author":"T Bittner","year":"2010","unstructured":"Bittner T, Fuhrmann M, Burgold S, Ochs SM, Hoffmann N, Mitteregger G, Kretzschmar H, LaFerla FM, Herms J. Multiple events lead to dendritic spine loss in triple transgenic Alzheimer\u2019s disease mice. PLoS One. 2010;5(11):e15477.","journal-title":"PLoS One"},{"key":"769_CR7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40035-017-0099-z","volume":"6","author":"P Maiti","year":"2017","unstructured":"Maiti P, Manna J, Dunbar GL. Current understanding of the molecular mechanisms in Parkinson\u2019s disease: targets for potential treatments. Transl Neurodegener. 2017;6:28.","journal-title":"Transl Neurodegener"},{"key":"769_CR8","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.neubiorev.2015.09.020","volume":"59","author":"P Maiti","year":"2015","unstructured":"Maiti P, Manna J, Ilavazhagan G, Rossignol J, Dunbar GL. Molecular regulation of dendritic spine dynamics and their potential impact on synaptic plasticity and neurological diseases. Neurosci Biobehav Rev. 2015;59:208\u201337.","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"769_CR9","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1093\/cercor\/bhn111","volume":"19","author":"S Knafo","year":"2009","unstructured":"Knafo S, Alonso-Nanclares L, Gonzalez-Soriano J, Merino-Serrais P, Fernaud-Espinosa I, Ferrer I, DeFelipe J. Widespread changes in dendritic spines in a model of Alzheimer\u2019s disease. Cereb Cortex. 2009;19(3):586\u201392.","journal-title":"Cereb Cortex"},{"issue":"7","key":"769_CR10","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1177\/1533317510382893","volume":"25","author":"Y Gong","year":"2010","unstructured":"Gong Y, Lippa C. Review: disruption of the postsynaptic density in Alzheimer\u2019s disease and other neurodegenerative dementias. Am J Alzheimers Dis Other Dement. 2010;25(7):547\u201355.","journal-title":"Am J Alzheimers Dis Other Dement"},{"key":"769_CR11","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1750-1326-9-48","volume":"9","author":"S Tu","year":"2014","unstructured":"Tu S, Okamoto S, Lipton SA, Xu H. Oligomeric Abeta-induced synaptic dysfunction in Alzheimer\u2019s disease. Mol Neurodegener. 2014;9:48.","journal-title":"Mol Neurodegener"},{"issue":"12","key":"769_CR12","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1007\/s12272-015-0648-x","volume":"38","author":"S Shadfar","year":"2015","unstructured":"Shadfar S, Hwang CJ, Lim MS, Choi DY, Hong JT. Involvement of inflammation in Alzheimer\u2019s disease pathogenesis and therapeutic potential of anti-inflammatory agents. Arch Pharm Res. 2015;38(12):2106\u201319.","journal-title":"Arch Pharm Res"},{"key":"769_CR13","doi-asserted-by":"crossref","unstructured":"Giorgetti S, Greco C, Tortora P, Aprile FA. Targeting amyloid aggregation: an overview of strategies and mechanisms. Int J Mol Sci. 2018;19(9): 2677","DOI":"10.3390\/ijms19092677"},{"issue":"2","key":"769_CR14","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2174\/157015907780866901","volume":"5","author":"S Chen","year":"2007","unstructured":"Chen S, Zhang XJ, Li L, Le WD. Current experimental therapy for Alzheimer\u2019s disease. Curr Neuropharmacol. 2007;5(2):127\u201334.","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"769_CR15","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12929-017-0355-7","volume":"24","author":"SY Hung","year":"2017","unstructured":"Hung SY, Fu WM. Drug candidates in clinical trials for Alzheimer\u2019s disease. J Biomed Sci. 2017;24(1):47.","journal-title":"J Biomed Sci"},{"issue":"3","key":"769_CR16","doi-asserted-by":"publisher","first-page":"843","DOI":"10.3233\/JAD-170512","volume":"61","author":"PH Reddy","year":"2018","unstructured":"Reddy PH, Manczak M, Yin X, Grady MC, Mitchell A, Tonk S, Kuruva CS, Bhatti JS, Kandimalla R, Vijayan M, et al. Protective effects of Indian spice curcumin against amyloid-beta in Alzheimer\u2019s disease. J Alzheimers Dis. 2018;61(3):843\u201366.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"769_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4103\/0972-2327.40220","volume":"11","author":"S Mishra","year":"2008","unstructured":"Mishra S, Palanivelu K. The effect of curcumin (turmeric) on Alzheimer\u2019s disease: an overview. Ann Indian Acad Neurol. 2008;11(1):13\u20139.","journal-title":"Ann Indian Acad Neurol"},{"key":"769_CR18","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1038\/s41598-020-58838-2","volume":"10","author":"F Ullah","year":"2020","unstructured":"Ullah F, Asgarov R, Venigalla M, Liang H, Niedermayer G, M\u00fcnch G, Gyengesi E. Effects of a solid lipid curcumin particle formulation on chronic activation of microglia and astroglia in the GFAP-IL6 mouse model. Sci Rep. 2020;10:2365 (2020).","journal-title":"Sci Rep"},{"key":"769_CR19","first-page":"4164872","volume":"2017","author":"P Maiti","year":"2017","unstructured":"Maiti P, Dunbar GL. Comparative neuroprotective effects of dietary curcumin and solid lipid curcumin particles in cultured mouse neuroblastomas after exposure to Abeta42. Int J Alzheimers Dis. 2017;2017:4164872.","journal-title":"Int J Alzheimers Dis"},{"key":"769_CR20","doi-asserted-by":"crossref","unstructured":"Maiti P, Dunbar GL. Use of curcumin, a natural polyphenol for targeting molecular pathways in treating age-related neurodegenerative diseases. Int J Mol Sci. 2018;19(6):1637.","DOI":"10.3390\/ijms19061637"},{"issue":"5","key":"769_CR21","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s00418-016-1464-1","volume":"146","author":"P Maiti","year":"2016","unstructured":"Maiti P, Hall TC, Paladugu L, Kolli N, Learman C, Rossignol J, Dunbar GL. A comparative study of dietary curcumin, nanocurcumin, and other classical amyloid-binding dyes for labeling and imaging of amyloid plaques in brain tissue of 5x-familial Alzheimer\u2019s disease mice. Histochem Biol. 2016;146(5):609\u201325.","journal-title":"Histochem Biol"},{"issue":"11","key":"769_CR22","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1111\/bph.13621","volume":"174","author":"AB Kunnumakkara","year":"2017","unstructured":"Kunnumakkara AB, Bordoloi D, Padmavathi G, Monisha J, Roy NK, Prasad S, Aggarwal BB. Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases. Br J Pharmacol. 2017;174(11):1325\u201348.","journal-title":"Br J Pharmacol"},{"issue":"6","key":"769_CR23","doi-asserted-by":"publisher","first-page":"4056","DOI":"10.1074\/jbc.M112.393751","volume":"288","author":"QL Ma","year":"2013","unstructured":"Ma QL, Zuo X, Yang F, Ubeda OJ, Gant DJ, Alaverdyan M, Teng E, Hu S, Chen PP, Maiti P, et al. Curcumin suppresses soluble tau dimers and corrects molecular chaperone, synaptic, and behavioral deficits in aged human tau transgenic mice. J Biol Chem. 2013;288(6):4056\u201365.","journal-title":"J Biol Chem"},{"issue":"1","key":"769_CR24","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1124\/jpet.108.137455","volume":"326","author":"AN Begum","year":"2008","unstructured":"Begum AN, Jones MR, Lim GP, Morihara T, Kim P, Heath DD, Rock CL, Pruitt MA, Yang F, Hudspeth B, et al. Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer\u2019s disease. J Pharmacol Exp Ther. 2008;326(1):196\u2013208.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"769_CR25","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3233\/JAD-140798","volume":"44","author":"R McClure","year":"2015","unstructured":"McClure R, Yanagisawa D, Stec D, Abdollahian D, Koktysh D, Xhillari D, Jaeger R, Stanwood G, Chekmenev E, Tooyama I, et al. Inhalable curcumin: offering the potential for translation to imaging and treatment of Alzheimer\u2019s disease. J Alzheimers Dis. 2015;44(1):283\u201395.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"769_CR26","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3233\/JAD-160289","volume":"55","author":"R McClure","year":"2017","unstructured":"McClure R, Ong H, Janve V, Barton S, Zhu M, Li B, Dawes M, Jerome WG, Anderson A, Massion P, et al. Aerosol delivery of curcumin reduced amyloid-beta deposition and improved cognitive performance in a transgenic model of Alzheimer\u2019s disease. J Alzheimers Dis. 2017;55(2):797\u2013811.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"769_CR27","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1177\/0394632016638099","volume":"29","author":"Y He","year":"2016","unstructured":"He Y, Wang P, Wei P, Feng H, Ren Y, Yang J, Rao Y, Shi J, Tian J. Effects of curcumin on synapses in APPswe\/PS1dE9 mice. Int J Immunopathol Pharmacol. 2016;29(2):217\u201325.","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"6","key":"769_CR28","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1021\/mp700113r","volume":"4","author":"P Anand","year":"2007","unstructured":"Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007;4(6):807\u201318.","journal-title":"Mol Pharm"},{"issue":"1","key":"769_CR29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12868-018-0406-3","volume":"19","author":"P Maiti","year":"2018","unstructured":"Maiti P, Paladugu L, Dunbar GL. Solid lipid curcumin particles provide greater anti-amyloid, anti-inflammatory and neuroprotective effects than curcumin in the 5xFAD mouse model of Alzheimer\u2019s disease. BMC Neurosci. 2018;19(1):7.","journal-title":"BMC Neurosci"},{"key":"769_CR30","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1475-2891-11-79","volume":"11","author":"RA DiSilvestro","year":"2012","unstructured":"DiSilvestro RA, Joseph E, Zhao S, Bomser J. Diverse effects of a low dose supplement of lipidated curcumin in healthy middle aged people. Nutr J. 2012;11:79.","journal-title":"Nutr J"},{"issue":"7","key":"769_CR31","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1089\/jmf.2014.0053","volume":"18","author":"PP Nahar","year":"2015","unstructured":"Nahar PP, Slitt AL, Seeram NP. Anti-inflammatory effects of novel standardized solid lipid curcumin formulations. J Med Food. 2015;18(7):786\u201392.","journal-title":"J Med Food"},{"issue":"5","key":"769_CR32","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1177\/0269881114552744","volume":"29","author":"KH Cox","year":"2015","unstructured":"Cox KH, Pipingas A, Scholey AB. Investigation of the effects of solid lipid curcumin on cognition and mood in a healthy older population. J Psychopharmacol. 2015;29(5):642\u201351.","journal-title":"J Psychopharmacol"},{"key":"769_CR33","doi-asserted-by":"crossref","unstructured":"Koronyo Y, Biggs D, Barron E, Boyer DS, Pearlman JA, Au WJ, Kile SJ, Blanco A, Fuchs DT, Ashfaq A, et al. Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer\u2019s disease. JCI Insight. 2017;2(16):e93621.","DOI":"10.1172\/jci.insight.93621"},{"key":"769_CR34","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/978-1-62703-444-9_29","volume":"1018","author":"G Das","year":"2013","unstructured":"Das G, Reuhl K, Zhou R. The Golgi-Cox method. Methods Mol Biol. 2013;1018:313\u201321.","journal-title":"Methods Mol Biol"},{"key":"769_CR35","doi-asserted-by":"crossref","unstructured":"Maiti P, Scott J, Sengupta D, Al-Gharaibeh A, Dunbar GL. Curcumin and solid lipid curcumin particles induce autophagy, but inhibit mitophagy and the PI3K-Akt\/mTOR pathway in cultured glioblastomas. Int J Mol Sci. 2019;20(2):399.","DOI":"10.3390\/ijms20020399"},{"issue":"25","key":"769_CR36","doi-asserted-by":"publisher","first-page":"17895","DOI":"10.1074\/jbc.M113.536565","volume":"289","author":"F Xu","year":"2014","unstructured":"Xu F, Kotarba AE, Ou-Yang MH, Fu Z, Davis J, Smith SO, Van Nostrand WE. Early-onset formation of parenchymal plaque amyloid abrogates cerebral microvascular amyloid accumulation in transgenic mice. J Biol Chem. 2014;289(25):17895\u2013908.","journal-title":"J Biol Chem"},{"issue":"1","key":"769_CR37","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3233\/JAD-140453","volume":"42","author":"JF Maya-Vetencourt","year":"2014","unstructured":"Maya-Vetencourt JF, Carucci NM, Capsoni S, Cattaneo A. Amyloid plaque-independent deficit of early postnatal visual cortical plasticity in the 5XFAD transgenic model of Alzheimer\u2019s disease. J Alzheimers Dis. 2014;42(1):103\u20137.","journal-title":"J Alzheimers Dis"},{"issue":"40","key":"769_CR38","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, Guillozet-Bongaarts A, Ohno M, Disterhoft J, Van Eldik L, et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J Neurosci. 2006;26(40):10129\u201340.","journal-title":"J Neurosci"},{"issue":"2","key":"769_CR39","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.nbd.2008.10.006","volume":"33","author":"R Kimura","year":"2009","unstructured":"Kimura R, Ohno M. Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model. Neurobiol Dis. 2009;33(2):229\u201335.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"769_CR40","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1460-9568.2005.04551.x","volume":"23","author":"M Ohno","year":"2006","unstructured":"Ohno M, Chang L, Tseng W, Oakley H, Citron M, Klein WL, Vassar R, Disterhoft JF. Temporal memory deficits in Alzheimer\u2019s mouse models: rescue by genetic deletion of BACE1. Eur J Neurosci. 2006;23(1):251\u201360.","journal-title":"Eur J Neurosci"},{"issue":"18","key":"769_CR41","doi-asserted-by":"publisher","first-page":"6664","DOI":"10.3390\/ijms21186664","volume":"21","author":"P Maiti","year":"2020","unstructured":"Maiti P, Manna J, Burch ZN, Flaherty DB, Larkin JD, Dunbar GL. Ameliorative properties of boronic compounds in in vitro and in vivo model\u2019s of Alzheimer\u2019s disease. Int J Mol Sci. 2020;21(18):6664.","journal-title":"Int J Mol Sci"},{"key":"769_CR42","volume":"96","author":"ML Seibenhener","year":"2015","unstructured":"Seibenhener ML, Wooten MC. Use of the open field maze to measure locomotor and anxiety-like behavior in mice. J Vis Exp. 2015;96:e52434.","journal-title":"J Vis Exp"},{"key":"769_CR43","doi-asserted-by":"crossref","unstructured":"Lueptow LM. Novel object recognition test for the investigation of learning and memory in mice. J Vis Exp. 2017;126:55718.","DOI":"10.3791\/55718-v"},{"issue":"2","key":"769_CR44","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.bbr.2008.01.007","volume":"189","author":"P Maiti","year":"2008","unstructured":"Maiti P, Muthuraju S, Ilavazhagan G, Singh SB. Hypobaric hypoxia induces dendritic plasticity in cortical and hippocampal pyramidal neurons in rat brain. Behav Brain Res. 2008;189(2):233\u201343.","journal-title":"Behav Brain Res"},{"issue":"3\u20134","key":"769_CR45","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jchemneu.2008.07.003","volume":"36","author":"P Maiti","year":"2008","unstructured":"Maiti P, Singh SB, Mallick B, Muthuraju S, Ilavazhagan G. High altitude memory impairment is due to neuronal apoptosis in hippocampus, cortex and striatum. J Chem Neuroanat. 2008;36(3\u20134):227\u201338.","journal-title":"J Chem Neuroanat"},{"issue":"2","key":"769_CR46","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0006-8993(02)02414-9","volume":"934","author":"IM Johansson","year":"2002","unstructured":"Johansson IM, Birzniece V, Lindblad C, Olsson T, Backstrom T. Allopregnanolone inhibits learning in the Morris water maze. Brain Res. 2002;934(2):125\u201331.","journal-title":"Brain Res"},{"key":"769_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2007.06.106","volume":"1175","author":"P Maiti","year":"2007","unstructured":"Maiti P, Singh SB, Muthuraju S, Veleri S, Ilavazhagan G. Hypobaric hypoxia damages the hippocampal pyramidal neurons in the rat brain. Brain Res. 2007;1175:1\u20139.","journal-title":"Brain Res"},{"issue":"8","key":"769_CR48","first-page":"5211","volume":"23","author":"P Maiti","year":"2019","unstructured":"Maiti P, Peruzzaro S, Kolli N, Andrews M, Al-Gharaibeh A, Rossignol J, Dunbar GL. Transplantation of mesenchymal stems overexpressing interleukin-10 induces autophagy response and promotes neuroprotection in a rat model of TBI. J Mol Med. 2019;23(8):5211\u201324.","journal-title":"J Mol Med"},{"issue":"1","key":"769_CR49","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0006-8993(96)01387-X","volume":"751","author":"LC Schmued","year":"1997","unstructured":"Schmued LC, Albertson C, Slikker W Jr. Fluoro-jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration. Brain Res. 1997;751(1):37\u201346.","journal-title":"Brain Res"},{"key":"769_CR50","doi-asserted-by":"crossref","unstructured":"Maiti P, Plemmons A, Bowers Z, Weaver C, Dunbar G. Labeling and imaging of amyloid plaques in brain tissue using the natural polyphenol curcumin. J Vis Exp. 2019; Nov 1; (153).","DOI":"10.3791\/60377-v"},{"issue":"4","key":"769_CR51","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.bcp.2013.12.012","volume":"88","author":"SM de la Monte","year":"2014","unstructured":"de la Monte SM, Tong M. Brain metabolic dysfunction at the core of Alzheimer\u2019s disease. Biochem Pharmacol. 2014;88(4):548\u201359.","journal-title":"Biochem Pharmacol"},{"key":"769_CR52","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/bs.apcsb.2019.08.003","volume":"118","author":"SI Liyanage","year":"2019","unstructured":"Liyanage SI, Weaver DF. Misfolded proteins as a therapeutic target in Alzheimer\u2019s disease. Adv Protein Chem Struct Biol. 2019;118:371\u2013411.","journal-title":"Adv Protein Chem Struct Biol"},{"issue":"1","key":"769_CR53","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13195-019-0529-5","volume":"11","author":"J Cummings","year":"2019","unstructured":"Cummings J, Feldman HH, Scheltens P. The \u201crights\u201d of precision drug development for Alzheimer\u2019s disease. Alzheimers Res Ther. 2019;11(1):76.","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"769_CR54","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1111\/j.1471-4159.2007.04613.x","volume":"102","author":"M Garcia-Alloza","year":"2007","unstructured":"Garcia-Alloza M, Borrelli LA, Rozkalne A, Hyman BT, Bacskai BJ. Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. J Neurochem. 2007;102(4):1095\u2013104.","journal-title":"J Neurochem"},{"issue":"21","key":"769_CR55","doi-asserted-by":"publisher","first-page":"8370","DOI":"10.1523\/JNEUROSCI.21-21-08370.2001","volume":"21","author":"GP Lim","year":"2001","unstructured":"Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci. 2001;21(21):8370\u20137.","journal-title":"J Neurosci"},{"issue":"6","key":"769_CR56","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1586\/14737175.2015.1044981","volume":"15","author":"S Hu","year":"2015","unstructured":"Hu S, Maiti P, Ma Q, Zuo X, Jones MR, Cole GM, Frautschy SA. Clinical development of curcumin in neurodegenerative disease. Expert Rev Neurother. 2015;15(6):629\u201337.","journal-title":"Expert Rev Neurother"},{"issue":"Suppl 1","key":"769_CR57","doi-asserted-by":"publisher","first-page":"S204","DOI":"10.1016\/j.neuroimage.2010.06.020","volume":"54","author":"M Koronyo-Hamaoui","year":"2011","unstructured":"Koronyo-Hamaoui M, Koronyo Y, Ljubimov AV, Miller CA, Ko MK, Black KL, Schwartz M, Farkas DL. Identification of amyloid plaques in retinas from Alzheimer\u2019s patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. Neuroimage. 2011;54(Suppl 1):S204\u201317.","journal-title":"Neuroimage."},{"issue":"4","key":"769_CR58","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v27.i4.10","volume":"27","author":"A Kumar","year":"2010","unstructured":"Kumar A, Ahuja A, Ali J, Baboota S. Conundrum and therapeutic potential of curcumin in drug delivery. Crit Rev Ther Drug Carrier Syst. 2010;27(4):279\u2013312.","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"issue":"3","key":"769_CR59","doi-asserted-by":"publisher","first-page":"327","DOI":"10.4062\/biomolther.2019.046","volume":"27","author":"J Kim","year":"2019","unstructured":"Kim J, Kim J, Huang Z, Goo N, Bae HJ, Jeong Y, Park HJ, Cai M, Cho K, Jung SY, et al. Theracurmin ameliorates cognitive dysfunctions in 5XFAD mice by improving synaptic function and mitigating oxidative stress. Biomol Ther (Seoul). 2019;27(3):327\u201335.","journal-title":"Biomol Ther (Seoul)"},{"issue":"7","key":"769_CR60","doi-asserted-by":"publisher","first-page":"5892","DOI":"10.1074\/jbc.M404751200","volume":"280","author":"F Yang","year":"2005","unstructured":"Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, Chen PP, Kayed R, Glabe CG, Frautschy SA, et al. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem. 2005;280(7):5892\u2013901.","journal-title":"J Biol Chem"},{"issue":"37","key":"769_CR61","doi-asserted-by":"publisher","first-page":"28472","DOI":"10.1074\/jbc.M110.133520","volume":"285","author":"C Zhang","year":"2010","unstructured":"Zhang C, Browne A, Child D, Tanzi RE. Curcumin decreases amyloid-beta peptide levels by attenuating the maturation of amyloid-beta precursor protein. J Biol Chem. 2010;285(37):28472\u201380.","journal-title":"J Biol Chem"},{"issue":"1","key":"769_CR62","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1021\/acschemneuro.5b00214","volume":"7","author":"A Thapa","year":"2016","unstructured":"Thapa A, Jett SD, Chi EY. Curcumin attenuates amyloid-beta aggregate toxicity and modulates amyloid-beta aggregation pathway. ACS Chem Neurosci. 2016;7(1):56\u201368.","journal-title":"ACS Chem Neurosci"},{"issue":"2","key":"769_CR63","first-page":"152","volume":"24","author":"M Padurariu","year":"2012","unstructured":"Padurariu M, Ciobica A, Mavroudis I, Fotiou D, Baloyannis S. Hippocampal neuronal loss in the CA1 and CA3 areas of Alzheimer\u2019s disease patients. Psychiatr Danub. 2012;24(2):152\u20138.","journal-title":"Psychiatr Danub"},{"issue":"1","key":"769_CR64","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/s41467-017-02751-2","volume":"9","author":"AC Frank","year":"2018","unstructured":"Frank AC, Huang S, Zhou M, Gdalyahu A, Kastellakis G, Silva TK, Lu E, Wen X, Poirazi P, Trachtenberg JT, et al. Hotspots of dendritic spine turnover facilitate clustered spine addition and learning and memory. Nat Commun. 2018;9(1):422.","journal-title":"Nat Commun"},{"issue":"2","key":"769_CR65","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/mp.2016.151","volume":"23","author":"X Yang","year":"2018","unstructured":"Yang X, Yao C, Tian T, Li X, Yan H, Wu J, Li H, Pei L, Liu D, Tian Q, et al. A novel mechanism of memory loss in Alzheimer\u2019s disease mice via the degeneration of entorhinal-CA1 synapses. Mol Psychiatry. 2018;23(2):199\u2013210.","journal-title":"Mol Psychiatry"},{"issue":"2","key":"769_CR66","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.neuron.2014.03.021","volume":"82","author":"M Bosch","year":"2014","unstructured":"Bosch M, Castro J, Saneyoshi T, Matsuno H, Sur M, Hayashi Y. Structural and molecular remodeling of dendritic spine substructures during long-term potentiation. Neuron. 2014;82(2):444\u201359.","journal-title":"Neuron."},{"issue":"3","key":"769_CR67","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1023\/B:NEUR.0000044197.83514.64","volume":"33","author":"DL Moolman","year":"2004","unstructured":"Moolman DL, Vitolo OV, Vonsattel JP, Shelanski ML. Dendrite and dendritic spine alterations in Alzheimer models. J Neurocytol. 2004;33(3):377\u201387.","journal-title":"J Neurocytol"},{"key":"769_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neures.2015.02.007","volume":"96","author":"P Maiti","year":"2015","unstructured":"Maiti P, Manna J, McDonald MP. Merging advanced technologies with classical methods to uncover dendritic spine dynamics: a hot spot of synaptic plasticity. Neurosci Res. 2015;96:1\u201313.","journal-title":"Neurosci Res"},{"issue":"1","key":"769_CR69","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s12035-008-8018-z","volume":"37","author":"M Knobloch","year":"2008","unstructured":"Knobloch M, Mansuy IM. Dendritic spine loss and synaptic alterations in Alzheimer\u2019s disease. Mol Neurobiol. 2008;37(1):73\u201382.","journal-title":"Mol Neurobiol"},{"issue":"43","key":"769_CR70","doi-asserted-by":"publisher","first-page":"14299","DOI":"10.1523\/JNEUROSCI.3383-10.2010","volume":"30","author":"D Tampellini","year":"2010","unstructured":"Tampellini D, Capetillo-Zarate E, Dumont M, Huang Z, Yu F, Lin MT, Gouras GK. Effects of synaptic modulation on beta-amyloid, synaptophysin, and memory performance in Alzheimer\u2019s disease transgenic mice. J Neurosci. 2010;30(43):14299\u2013304.","journal-title":"J Neurosci"},{"issue":"2","key":"769_CR71","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.neuroscience.2009.04.046","volume":"162","author":"U Schmitt","year":"2009","unstructured":"Schmitt U, Tanimoto N, Seeliger M, Schaeffel F, Leube RE. Detection of behavioral alterations and learning deficits in mice lacking synaptophysin. Neuroscience. 2009;162(2):234\u201343.","journal-title":"Neuroscience."},{"issue":"3","key":"769_CR72","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00401-011-0843-x","volume":"122","author":"CY Shao","year":"2011","unstructured":"Shao CY, Mirra SS, Sait HB, Sacktor TC, Sigurdsson EM. Postsynaptic degeneration as revealed by PSD-95 reduction occurs after advanced Abeta and tau pathology in transgenic mouse models of Alzheimer\u2019s disease. Acta Neuropathol. 2011;122(3):285\u201392.","journal-title":"Acta Neuropathol"},{"issue":"6","key":"769_CR73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0131525","volume":"10","author":"L Zhang","year":"2015","unstructured":"Zhang L, Fang Y, Xu Y, Lian Y, Xie N, Wu T, Zhang H, Sun L, Zhang R, Wang Z. Curcumin improves amyloid beta-peptide (1-42) induced spatial memory deficits through BDNF-ERK signaling pathway. PLoS One. 2015;10(6):e0131525.","journal-title":"PLoS One"},{"issue":"3","key":"769_CR74","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1007\/s12035-016-9802-9","volume":"54","author":"K Zheng","year":"2017","unstructured":"Zheng K, Dai X, Xiao N, Wu X, Wei Z, Fang W, Zhu Y, Zhang J, Chen X. Curcumin ameliorates memory decline via inhibiting BACE1 expression and beta-amyloid pathology in 5xFAD transgenic mice. Mol Neurobiol. 2017;54(3):1967\u201377.","journal-title":"Mol Neurobiol"},{"key":"769_CR75","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.brainres.2009.07.056","volume":"1292","author":"Y Gong","year":"2009","unstructured":"Gong Y, Lippa CF, Zhu J, Lin Q, Rosso AL. Disruption of glutamate receptors at shank-postsynaptic platform in Alzheimer\u2019s disease. Brain Res. 2009;1292:191\u20138.","journal-title":"Brain Res"},{"issue":"3","key":"769_CR76","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jagp.2017.10.010","volume":"26","author":"GW Small","year":"2018","unstructured":"Small GW, Siddarth P, Li Z, Miller KJ, Ercoli L, Emerson ND, Martinez J, Wong KP, Liu J, Merrill DA, et al. Memory and brain amyloid and tau effects of a bioavailable form of curcumin in non-demented adults. A double-blind, placebo-controlled 18-month trial. Am J Geriatr Psychiatry. 2018;26(3):266\u201377.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"5","key":"769_CR77","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.neurobiolaging.2008.06.002","volume":"31","author":"RS Rosenbaum","year":"2010","unstructured":"Rosenbaum RS, Furey ML, Horwitz B, Grady CL. Altered connectivity among emotion-related brain regions during short-term memory in Alzheimer\u2019s disease. Neurobiol Aging. 2010;31(5):780\u20136.","journal-title":"Neurobiol Aging"},{"key":"769_CR78","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1750-1326-7-12","volume":"7","author":"MA Hickey","year":"2012","unstructured":"Hickey MA, Zhu C, Medvedeva V, Lerner RP, Patassini S, Franich NR, Maiti P, Frautschy SA, Zeitlin S, Levine MS, et al. Improvement of neuropathology and transcriptional deficits in CAG 140 knock-in mice supports a beneficial effect of dietary curcumin in Huntington\u2019s disease. Mol Neurodegener. 2012;7:12.","journal-title":"Mol Neurodegener"},{"key":"769_CR79","doi-asserted-by":"crossref","unstructured":"Gharaibeh, A, Maiti P, Culver R, Heileman S, Srinageshwar B, Story D, Spelde K, Paladugu L, Munro N, Muhn N, Kolli N, Rossignol R and Dunbar GL. Solid Lipid Curcumin Particles Protect Medium Spiny Neuronal Morphology, and Reduce Learning and Memory Deficits in the YAC128 Mouse Model of Huntington's Disease. Int. J. Mol. Sci. 2020, 21, 9542.","DOI":"10.3390\/ijms21249542"}],"updated-by":[{"DOI":"10.1186\/s13195-022-00980-2","type":"correction","label":"Correction","source":"retraction-watch","updated":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T00:00:00Z","timestamp":1646870400000},"record-id":"47763"},{"DOI":"10.1186\/s13195-023-01313-7","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T00:00:00Z","timestamp":1695945600000},"record-id":"47762"},{"DOI":"10.1186\/s13195-022-00980-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T00:00:00Z","timestamp":1646870400000}},{"DOI":"10.1186\/s13195-023-01313-7","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T00:00:00Z","timestamp":1695945600000}}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-021-00769-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-021-00769-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-021-00769-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T09:05:44Z","timestamp":1696496744000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-021-00769-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,8]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["769"],"URL":"https:\/\/doi.org\/10.1186\/s13195-021-00769-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-27472\/v1","asserted-by":"object"}]},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,8]]},"assertion":[{"value":"8 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13195-022-00980-2","URL":"https:\/\/doi.org\/10.1186\/s13195-022-00980-2","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2023","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the Retraction Notice for more detail:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13195-023-01313-7","URL":"https:\/\/doi.org\/10.1186\/s13195-023-01313-7","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was carried out in strict accordance with the protocols approved by the Institutional Animal Care and Use Committee of the Saginaw Valley State University (IACUC no- 1513829-1).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37"}}